Empresa DA32 Life Science Tech Acquisition Corp.
Acciones
DALS
US23312M1062
Holding Companies
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/04/21 |
Chris Wolfe
DFI | Director of Finance/CFO | 44 | 01/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
E. Hrusovsky
BRD | Director/Board Member | 63 | 27/07/21 |
Keith Crandell
BRD | Director/Board Member | 63 | 27/07/21 |
Nicolas Roelofs
BRD | Director/Board Member | 66 | 27/07/21 |
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/04/21 |
Angela Lai
BRD | Director/Board Member | - | 27/07/21 |
Director/Board Member | 42 | 27/07/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 000 000 | 0 | 0 | 77,01 % |
Acción B | 1 | 20 650 000 | 19 752 807 ( 95,66 %) | 0 |
Información de la empresa
DA32 Life Science Tech Acquisition Corp.
345 Park Avenue South 12th floor
10010, New York
+
Varia. 1 de ene. | Capi. | |
---|---|---|
+137,37 % | 5678,54 M | |
+1,89 % | 1012,5 M | |
+2,19 % | 982 M | |
+41,91 % | 872 M | |
+25,27 % | 819 M | |
+1,68 % | 663 M | |
+0,54 % | 610 M | |
-.--% | 600 M | |
+21,31 % | 552 M |